Partridge Andrew John

CIK: 0001758838
Primary company: Turning Point Therapeutics, Inc. (TPTX)

Partridge Andrew John is a corporate insider at Turning Point Therapeutics, Inc. (TPTX) filing SEC Form 4 transactions. 9 transactions, totaling $0 in purchases and $148,010 in sales. Source: SEC EDGAR.

Total Transactions
9
Total Buy Value
$0
Total Sell Value
$148K
Net Activity
$-148K
Last Transaction
Jun 2026
Companies
1

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Sale
Shares
1,491
Price
$61.08
Value
$91K
Turning Point Therapeutics, Inc.
TPTX
Type
Award
Shares
58,600
Price
$0.00
Value
$0
Turning Point Therapeutics, Inc.
TPTX
Type
Award
Shares
16,283
Price
$0.00
Value
$0
Turning Point Therapeutics, Inc.
TPTX
Type
Sale
Shares
221
Price
$36.30
Value
$8K
Turning Point Therapeutics, Inc.
TPTX
Type
Sale
Shares
1,869
Price
$74.90
Value
$140K
Turning Point Therapeutics, Inc.
TPTX
Type
Award
Shares
9,733
Price
$0.00
Value
$0
Turning Point Therapeutics, Inc.
TPTX
Type
Award
Shares
2,136
Price
$0.00
Value
$0
Turning Point Therapeutics, Inc.
TPTX
Type
Award
Shares
127,500
Price
$0.00
Value
$0
Turning Point Therapeutics, Inc.
TPTX
Type
Award
Shares
21,500
Price
$0.00
Value
$0